Atossa Therapeutics (MEX:ATOS) Cyclically Adjusted Book per Share: MXN684.73 (As of Mar. 2026)


MEX:ATOS Atossa Therapeutics Inc MEX:ATOS
28 GF Score
Price MXN32.50
! 2 Warning Signs
View Full Analysis

What is Atossa Therapeutics Cyclically Adjusted Book per Share?

Atossa Therapeutics MEX:ATOS +4.84% 28 Cyclically Adjusted Book per Share is MXN684.73 as of Mar. 2026. GuruFocus rates MEX:ATOS with a GF Score™ of 28/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Atossa Therapeutics's adjusted book value per share for the three months ended in Mar. 2026 was MXN63.842. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN684.73 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Atossa Therapeutics's average Cyclically Adjusted Book Growth Rate was -67.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -55.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -37.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Atossa Therapeutics was -1.60% per year. The lowest was -55.50% per year. And the median was -24.40% per year.

As of today (2026-06-27), Atossa Therapeutics's current stock price is MXN32.50. Atossa Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was MXN684.73. Atossa Therapeutics's Cyclically Adjusted PB Ratio of today is 0.05.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Atossa Therapeutics was 0.04. The lowest was 0.00. And the median was 0.00.


Atossa Therapeutics  (MEX:ATOS) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Atossa Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=32.50/684.73
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Atossa Therapeutics was 0.04. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Atossa Therapeutics Cyclically Adjusted Book per Share Related Terms


Atossa Therapeutics Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Atossa Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Atossa Therapeutics Cyclically Adjusted Book per Share Chart

Atossa Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,265.60 10,998.02 6,312.24 3,554.27 1,054.63

Atossa Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,861.86 1,828.38 1,088.40 1,054.63 684.73

MEX:ATOS vs LTRN, ESLA, NTRB: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Atossa Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atossa Therapeutics Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atossa Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Atossa Therapeutics's Cyclically Adjusted PB Ratio falls into.


MEX:ATOS
28GF Score
Atossa Therapeutics Inc MEX:ATOS
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Atossa Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Atossa Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=63.842/330.2130*330.2130
=63.842

Current CPI (Mar. 2026) = 330.2130.

Atossa Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201606 2,971.267 241.018 4,070.862
201609 4,984.857 241.428 6,818.035
201612 3,040.524 241.432 4,158.606
201703 1,370.048 243.801 1,855.643
201706 905.089 244.955 1,220.110
201709 596.321 246.819 797.803
201712 769.932 246.524 1,031.305
201803 539.898 249.554 714.400
201806 820.262 251.989 1,074.893
201809 537.209 252.439 702.718
201812 443.297 251.233 582.656
201903 622.012 254.202 808.005
201906 553.621 256.143 713.714
201909 486.839 256.759 626.115
201912 407.425 256.974 523.543
202003 419.522 258.115 536.705
202006 311.758 257.797 399.332
202009 312.407 260.280 396.346
202012 170.481 260.474 216.125
202103 354.516 264.877 441.963
202106 341.620 271.696 415.197
202109 344.278 274.310 414.440
202112 335.670 278.802 397.567
202203 318.774 287.504 366.128
202206 310.411 296.311 345.926
202209 295.115 296.808 328.329
202212 272.427 296.797 303.099
202303 241.819 301.836 264.554
202306 213.185 305.109 230.726
202309 204.863 307.789 219.788
202312 184.933 306.746 199.081
202403 170.106 312.332 179.845
202406 175.164 314.175 184.106
202409 172.982 315.301 181.163
202412 173.116 315.605 181.129
202503 155.193 319.799 160.247
202506 126.159 322.561 129.152
202509 106.062 324.800 107.830
202512 82.288 324.054 83.852
202603 63.842 330.213 63.842

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of MXN684.73 mean?
Atossa Therapeutics (MEX:ATOS) has a Cyclically Adjusted Book per Share of MXN684.73 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Atossa Therapeutics and its competitors.
Is Atossa Therapeutics' Cyclically Adjusted Book per Share too high?
Atossa Therapeutics' current Cyclically Adjusted Book per Share is MXN684.73. Overall, Atossa Therapeutics has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Atossa Therapeutics' Cyclically Adjusted Book per Share compare to LTRN and ESLA?
Atossa Therapeutics' Cyclically Adjusted Book per Share of MXN684.73 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Atossa Therapeutics and its competitors. Atossa Therapeutics's current Cyclically Adjusted Book per Share is MXN684.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atossa Therapeutics stock overvalued right now?
Atossa Therapeutics (MEX:ATOS) has a current Cyclically Adjusted Book per Share of MXN684.73. The current Cyclically Adjusted Book per Share is MXN684.73. Atossa Therapeutics' overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Atossa Therapeutics (MEX:ATOS), the current Cyclically Adjusted Book per Share is MXN684.73 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Atossa Therapeutics Business Description

Other Exchanges ATOS:USAYAG:Germany
Address 1448 NW Market Street, Suite 500, Seattle, WA, USA, 98107
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
28GF Score

Get the complete analysis for MEX:ATOS

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN32.50
Price